Nutrition supplement maker Glanbia has reported higher revenues and basic earnings per share for 2025 despite what it called a challenging macroeconomic and operating environment.
Glanbia said its revenues for the year to January 3, 2026 rose by 2.3% to $3.9 billion from $3.8 billion the previous year, while its basic earnings per share jumped by 19.7% to 73.15 cent from 63.21 cent.
But its EBITDA fell by 9.4% to $499.1m from $551.3m.
Glanbia said it was recommending a final dividend per share of 25.67 cent, which represented a total 2025 dividend of 42.87 cent, a 10% increase on the previous year.
The company reported volume and like-for-like revenue growth across all of its three segments, with performance somewhat offset by record whey inflation.
During the year, Glanbia said it returned about €197m to shareholders via its share buyback programme. It also announced today its Board has approved authority for an additional €100m of share buybacks.
It said its Optimum Nutrition division saw double digit volume growth in the second half of the year, while it also saw strong volume growth across its Health & Nutrition and Dairy Nutrition divisions.
In September, Glanbia sold its weight management brand SlimFast US to US-based Heartland Food Products Group - which makes the Spenda brand of low calorie sweeteners, drink mixes, coffee and nutritional beverages - for an undisclosed sum.
Glanbia had bought SlimFast for $350m in 2018, but sales of its products have plummeted since 2022 as weight-loss drugs upended the diet market and consumers moved away from the low-carbohydrate diets that the 50-year-old brand supports.
During the year it also announced the acquisitions of Sweetmix and Scicore, which it said will build out further global scale in its Health & Nutrition division.
"Glanbia is a protein powerhouse at the heart of better nutrition with a portfolio of world-class brands and ingredients that help consumers globally achieve their everyday fitness, health and nutrition goals," Glanbia's chief executive Hugh McGuire said.
"In line with our new medium-term guidance, we expect adjusted EPS growth of 7% to 11% constant currency in 2026, which will be driven by category and end-use market demand and a strong operating performance across all three segments," he added.
Glanbia shares moved higher in Dublin trade today.
